MassBio

In this interactive workshop, we’ll explore how a group of stakeholders within the Duchenne muscular dystrophy (DMD) community approaches its work and what we can learn from their successes and failures to apply to other disease areas. We’ll hear from an industry CEO, a patient, a patient advocate, and a researcher. We will then split into smaller groups to discuss before coming back together to report our findings.